Clinical relevance of antifungal resistance

Infectious Disease Clinics of North America

Volumn 11, Issue 4, 1997, Pages 929-944

  Espinel Ingroff, A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

CANDIDIASIS; DRUG RESISTANCE; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME;

EID: 0031435019     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70398-6     Document Type: Article

References (81)

1. G. Albertson M. Niimi R. Cannon Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance Antimicrob Agents Chemother 40 1996 2835 2841
2. E. Anaissie H. Kantarjian J. Ro The emerging role of Fusarium infections in patients with cancer Medicine 67 1988 77 83
3. E. Anaissie R. Hachem C. Legrand Lack of activity of amphotericin B in systemic murine fusarial infection J Infect Dis 165 1992 1155 1157
4. E. Anaissie N. Karyotakis R. Hachem Correlation between in vitro and in vivo activity of antifungal agents against Candida species J Infect Dis 170 1994 384 389
5. G. Baily F. Perry D. Denning Fluconazole-resistant candidosis in an HIV cohort AIDS 8 1994 787 792
6. F. Barchiesi R. Hollis D. McGough DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS Clin Infect Dis 20 1995 634 640
7. J. Berenguer T. Diaz-Guerra Ruiz-Diez Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient J Clin Microbiol 34 1996 1542 1545
8. D. Boken S. Swindells M. Rinaldi Fluconazole-resistant Candida albicans Clin Infect Dis 17 1993 1018 1021
9. H. Calvet M. Yeaman S. Filler Reversible fluconazole resistance in Candida albicans : a potential in vitro model Antimicrob Agents Chemother 4 1997 535 539
10. J. Cartledge J. Midgley B. Gazzard Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis AIDS 11 1997 163 168
11. A. Casadevall E. Spitzer D. Webb Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole Antimicrob Agents Chemother 37 1993 1383 1386
12. F. Clark T. Parkinson C. Hitchcock Correlation between Rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance Antimicrob Agents Chemother 40 1996 419 425
13. J. Conly R. Rennie J. Johnson Disseminated candidiasis due to amphotericin B-resistant Candida albicans J Infect Dis 165 1992 761 764
14. B. Currie M. Ghannoum L. Bessen Decreased fluconazole susceptibility of a relapse Cryptococcus neoformans isolate after fluconazole treatment Infect Dis Clin Pract 4 1995 318 319
15. D. D'Antonio A. Mazoni A. Iacone Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients J Clin Microbiol 34 1996 753 755
16. J. Dick W. Merz R. Saral Incidence of polyene-resistant yeasts recovered from clinical specimens Antimicrob Agents Chemother 18 1980 158 163
17. J. Dick B. Rosengard W. Merz Fatal disseminated candidiasis due to amphotericin B resistant Candida guilliermondii Ann Intern Med 102 1985 67 68
18. A. Espinel-Ingroff M. Bartlett R. Bowden Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi J Clin Microbiol 35 1997 139 143
19. T. Evans J. Mayer S. Cohen Fluconazole failure in the treatment of invasive mycoses J Infect Dis 164 1991 1232 1235
20. M. Ghannoum J. Rex J. Galgiani Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome J Clin Microbiol 34 1996 489 495
21. C. Girmenia P. Martino De Bernardis F. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains Clin Infect Dis 23 1996 506 514
22. C. Gonzalez D. Venzon S. Lee Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study Clin Infect Dis 23 1996 515 521
23. R. Guennec J. Reynes M. Mallié Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities J Clin Microbiol 33 1995 2732 2737
24. R. Guinet J. Chanas A. Goullier Fatal septicemia due to amphotericin B-resistant Candida lusitaniae J Clin Microbiol 18 1983 443 444
25. S. Hawser L. Douglas Resistance of Candida albicans biofilms to antifungal agents in vitro Antimicrob Agents Chemother 39 1995 2128 2131
26. X. He R. Tiballi L. Zarins Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus Antimicrob Agents Chemother 38 1994 2495 2497
27. G. Heinic D. Stevens D. Greenspan Fluconazole-resistant Candida in AIDS patients Oral Surg Oral Med Oral Pathol 76 1993 711 715
28. C. Hennequin M. Labenne M. Benkerrou Fluconazole-resistant Candida albicans in an immunocompetent child Clin Infect Dis 19 1994 1179 1180
29. C. Higgins ABC transporters: from microorganisms to man Annu Rev Cell Biol 8 1992 67 113
30. C. Hitchock Resistance of Candida albicans to azole antifungal agents Biochem Society Transactions 21 1993 1039 1047
31. 22-desaturase, and inhibition by azole antifungal agents J Biol Chem 272 1997 9986 9988
32. F. Lacassin F. Damond C. Chochillon Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors Antimicrob Agents Chemother 40 1996 1961 1963
33. F. Laguna J. Rodríguez-Tudela J. Martínez-Suárez Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans Clin Infect Dis 24 1997 124 130
34. J. Maenza W. Merz M. Romagnoli Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology Clin Infect Dis 24 1997 28 34
35. P. Marichal J. Gorrens M. Coene Origin of differences in susceptibility of Candida krusei to azole antifungal agents Mycoses 38 1995 111 117
36. F. Menichetti M. Fiorio A. Tosti High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS Clin Infect Dis 22 1996 838 840
37. W. Merz G. Sandford Isolation and characterization of a polyene-resistant variant of Candida tropicalis J Clin Microbiol 9 1979 677 680
38. W. Merz Candida lusitaniae : Frequency of recovery, colonization, infection, and amphotericin-B resistance J Clin Microbiol 20 1984 1194 1195
39. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P 1992 National Committee for Clinical Laboratory Standards Villanova, Pa
40. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27T 1995 National Committee for Clinical Laboratory Standards Villanova, Pa
41. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27A 1997 National Committee for Clinical Laboratory Standards Villanova, Pa
42. S. Newman T. Flanigan A. Fisher Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS Clin Infect Dis 19 1994 684 686
43. D. Pappagianis M. Collins R. Hector Development of resistance to amphotericin B in Candida lusitaniae infecting a human Antimicrob Agents Chemother 16 1979 123 126
44. T. Parkinson D. Falconer C. Hitchcock Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata Antimicrob Agents Chemother 39 1995 1696 1699
45. M. Pfaller M. Bale B. Buschelman Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine J Clin Microbiol 33 1995 1104 1107
46. W. Powderly G. Kobayashi G. Herzig Amphotericin B-resistant yeast infection in severely immunocompromised patients Am J Med 84 1988 826 832
47. W. Powderly Editorial response: management of cryptococcal meningitis—have we answered all the questions? Clin Infect Dis 22 1996 329 330
48. W. Powderly The problem of azole resistant candidiasis HIV Newsline 1997
49. M. Rabodonirina S. Paulus F. Thevenet Disseminated Scedosporium prolificans (S. inflatum) infection after single lung-transplantation Clin Infect Dis 19 1994 138 142
50. S. Redding J. Smith G. Farinacci Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis Clin Infect Dis 18 1994 240 242
51. J. Rex M. Pfaller A. Barry Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia Antimicrob Agents Chemother 39 1995 40 44
52. J. Rex M. Rinaldi M. Pfaller Resistance of Candida species to fluconazole Antimicrob Agents Chemother 39 1995 1 8
53. J. Rex M. Pfaller M. Lancaster Quality control guidelines for National Committee for Clinical Laboratory Standards—recommended broth macrodilution testing of ketoconazole and itraconazole J Clin Microbiol 34 1996 816 817
54. J. Rex M. Pfaller J. Galgiani Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro–in vivo correlation data for fluconazole, itraconazole, and Candida infections Clin Infect Dis 24 1997 235 247
55. J. Rodriguez-Tudela J. Martinez-Suárez F. Dronda Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients J Antimicrob Chemother 35 1995 793 804
56. M. Ruhnke A. Eigler I. Tennagen Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection J Clin Microbiol 32 1994 2092 2098
57. M. Ruhnke A. Schmidt-Westhausen E. Engelmann Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy J Clin Microbiol 34 1996 3208 3211
58. C. Sánchez E. Mauri D. Dalmau Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? Clin Infect Dis 21 1995 1485 1487
59. P. Sandven A. Bjørneklett A. Maeland Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance Antimicrob Agents Chemother 37 1993 2443 2448
60. J. Sangeorzan S. Bradley X. He Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance Am J Med 97 1994 339 353
61. D. Sanglard K. Kuchler F. Ischer Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters Antimicrob Agents Chemother 39 1995 2378 2386
62. D. Sanglard F. Ischer M. Monod Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors Antimicrob Agents Chemother 40 1996 2300 2305
63. A. Schaffner P. Frick The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis J Infect Dis 151 1985 902 910
64. 3: demonstration of efficacy in a prospective, multicenter trial Clin Infect Dis 23 1996 1282 1286
65. J. Sobel J. Vazquez Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus Clin Infect Dis 22 1996 726 727
66. Sterling T. Gasser R. Jr A. Ziegler Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host Clin Infect Dis 23 1996 187 188
67. R. Stiller J. Bennett H. Scholer Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model J Infect Dis 147 1983 1070 1077
68. N. Troillet C. Durussel J. Bille Correlation between in vitro susceptibility of Candida albicans and fluconazole resistant oropharyngeal candidiasis in HIV-infected patients Eur J Clin Microbiol Infect Dis 12 1993 911 915
69. R. Tucker D. Denning L. Hanson Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations Clin Infect Dis 14 1992 165 174
70. M. Tumbarello N. Bevilacqua G. Federico Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS Clin Infect Dis 22 1996 179 180
71. Vanden Bossche H. P. Marichal J. Gorrens Mutation in cytochrome P450-dependent 14 α-demethylase results in decreased affinity for azole antifungals Biochem Soc Trans 18 1990 56 59
72. Vanden Bossche H. P. Marichal F. Odds Characterization of an azole-resistant Candida glabrata isolate Antimicrob Agents Chemother 36 1992 2602 2610
73. Vanden Bossche H. P. Marichal F. Odds Molecular mechanisms of drug resistance in fungi Trends Microbiol 2 1994 393 400
74. J. Vazquez M. Arganoza J. Vaishampayan In vitro interaction between amphotericin B and azoles in Candida albicans Antimicrob Agents Chemother 40 1996 2511 2516
75. J. Velez R. Allendoerfer M. Luther Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis J Infect Dis 168 1993 508 510
76. K. Venkateswarlu D. Denning N. Manning Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance Antimicrob Agents Chemother 40 1996 2443 2446
77. K. Venkateswarlu D. Denning S. Kelly Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs J Medical Veterinary Mycology 35 1997 19 25
78. L. Willocks C. Leen R. Brettle Fluconazole resistance in AIDS patients J Antimicrob Chemother 28 1991 937 939
79. C. Wilson E. O'Rourke M. McGinnis Scedosporium inflatum : Clinical spectrum of a newly recognized pathogen J Infect Dis 161 1990 102 107
80. J. Wingard W. Merz R. Saral Candida tropicalis : a major pathogen in immunocompromised patients Ann Intern Med 91 1979 539 543
81. M. Witt R. Lewis R. Larsen Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing Clin Infect Dis 22 1996 322 328